Competitors
| Companies | Market Cap | G | R | O | W | T | H |
|---|---|---|---|---|---|---|---|
|
Roivant Sciences NasdaqGS:ROIV |
19,83 B | -17,10% | 2/4 | -76,60% | -577,01% | 24,50% | UP |
|
GW Pharmaceuticals NasdaqGM:GWPH |
6,91 B | 0,00% | 0,00% | 0,00% | 0,00% | DOWN | |
|
Centessa Pharmaceuticals NasdaqGS:CNTA |
5,80 B | 0,00% | 0/0 | 0,00% | 0,00% | 8,29% | UP |
|
Abcam NasdaqGM:ABCM |
3,56 B | -48,52% | 1/4 | 0,00% | 0,00% | -100,00% | UP |
|
Kiniksa Pharmaceuticals International NasdaqGS:KNSA |
3,69 B | 25,28% | 3/4 | 76,45% | -85,76% | 17,34% | UP |
|
Genus LSE:GNS |
1,59 B | 1,49% | 4/6 | 14,83% | 23,58% | 37,13% | DOWN |
|
Immunocore Holdings NasdaqGS:IMCR |
1,53 B | 53,28% | 5/6 | 12,68% | 33,26% | 105,64% | DOWN |
|
Oxford Nanopore Technologies LSE:ONT |
1,07 B | -0,86% | 1/5 | 20,55% | 5,09% | 75,68% | DOWN |
|
Oxford Biomedica LSE:OXB |
0,66 B | 5,57% | 1/6 | 35,25% | -54,29% | 47,34% | DOWN |
|
COMPASS Pathways NasdaqGS:CMPS |
0,71 B | 0,00% | 1/4 | 0,00% | 0,00% | 235,75% | DOWN |
|
Exscientia NasdaqGS:EXAI |
0,63 B | 0,00% | 0/0 | 79,95% | 0,00% | 29,96% | DOWN |
|
Urovant Sciences NasdaqGM:UROV |
0,52 B | 0,00% | 0/0 | 0,00% | 0,00% | -100,00% | DOWN |
|
Orchard Therapeutics NasdaqGM:ORTX |
0,38 B | 0,00% | 4/5 | 81,10% | -9,00% | -100,00% | UP |
|
Autolus Therapeutics NasdaqGS:AUTL |
0,37 B | 53,86% | 2/5 | 76,51% | 95,51% | 552,17% | DOWN |
|
NIOX Group Plc AIM:NIOX |
0,25 B | 23,70% | 5/6 | 48,39% | 15,69% | 38,98% | DOWN |
|
Bicycle Therapeutics NasdaqGS:BCYC |
0,32 B | -7,85% | 0/5 | -55,19% | 76,77% | 72,41% | DOWN |
|
Silence Therapeutics NasdaqGM:SLN |
0,25 B | 46,48% | 2/6 | -87,89% | 54,93% | 374,38% | DOWN |
|
Horizon Discovery Group AIM:HZD |
0,16 B | 0,00% | 0,00% | 0,00% | 0,00% | DOWN | |
|
Tiziana Life Sciences Ltd NasdaqCM:TLSA |
0,15 B | 0,00% | 1/4 | 0,00% | 0,00% | 569,23% | DOWN |
|
Scancell Holdings AIM:SCLP |
0,12 B | 0,00% | 2/5 | 0,00% | 0,00% | 181,82% | UP |
